134 related articles for article (PubMed ID: 8180127)
1. Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors.
Powell CT; Fair WR; Heston WD
Cell Growth Differ; 1994 Feb; 5(2):143-9. PubMed ID: 8180127
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.
Powell CT; Gschwend JE; Fair WR; Brittis NJ; Stec D; Huryk R
Cancer Res; 1996 Sep; 56(18):4137-41. PubMed ID: 8797581
[TBL] [Abstract][Full Text] [Related]
3. Expression and localization of androgen receptor in the R-3327 Dunning rat prostatic adenocarcinoma.
Quarmby VE; Beckman WC; Cooke DB; Lubahn DB; Joseph DR; Wilson EM; French FS
Cancer Res; 1990 Feb; 50(3):735-9. PubMed ID: 2404576
[TBL] [Abstract][Full Text] [Related]
4. Functional effects of overexpression of protein kinase C-alpha, -beta, -delta, -epsilon, and -eta in the mast cell line RBL-2H3.
Chang EY; Szallasi Z; Acs P; Raizada V; Wolfe PC; Fewtrell C; Blumberg PM; Rivera J
J Immunol; 1997 Sep; 159(6):2624-32. PubMed ID: 9300681
[TBL] [Abstract][Full Text] [Related]
5. Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis.
Bussemakers MJ; van de Ven WJ; Debruyne FM; Schalken JA
Cancer Res; 1991 Jan; 51(2):606-11. PubMed ID: 1702360
[TBL] [Abstract][Full Text] [Related]
6. Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate.
Koren R; Ben Meir D; Langzam L; Dekel Y; Konichezky M; Baniel J; Livne PM; Gal R; Sampson SR
Oncol Rep; 2004 Feb; 11(2):321-6. PubMed ID: 14719062
[TBL] [Abstract][Full Text] [Related]
7. Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublines.
Tieva A; Bergh A; Damber JE
Acta Oncol; 2005; 44(3):299-303. PubMed ID: 16076703
[TBL] [Abstract][Full Text] [Related]
8. Increased protein kinase C delta in mammary tumor cells: relationship to transformtion and metastatic progression.
Kiley SC; Clark KJ; Duddy SK; Welch DR; Jaken S
Oncogene; 1999 Nov; 18(48):6748-57. PubMed ID: 10597283
[TBL] [Abstract][Full Text] [Related]
9. Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta, -epsilon, and -zeta isozyme levels in proliferating human melanoma cells.
Krasagakis K; Fimmel S; Genten D; Eberle J; Quas P; Ziegler W; Haller H; Orfanos CE
Int J Oncol; 2002 Apr; 20(4):865-71. PubMed ID: 11894137
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C activity and messenger RNA modulation by estrogen in normal and neoplastic rat pituitary tissue.
Maeda T; Lloyd RV
Lab Invest; 1993 Apr; 68(4):472-80. PubMed ID: 8479155
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid regulation of protein kinase C isoforms in prostate cancer cells.
Pandian SS; Sneddon AA; Bestwick CS; McClinton S; Grant I; Wahle KW; Heys SD
Biochem Biophys Res Commun; 2001 May; 283(4):806-12. PubMed ID: 11350056
[TBL] [Abstract][Full Text] [Related]
12. Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma.
Epner DE; Partin AW; Schalken JA; Isaacs JT; Coffey DS
Cancer Res; 1993 May; 53(9):1995-7. PubMed ID: 8481901
[TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of calcium-independent protein kinase C in NG 108-15 cell differentiation.
Battaini F; Pascale A; Lucchi L; Racchi M; Bergamaschi S; Parenti M; Wetsel WC; Govoni S; Trabucchi M
Biochem Biophys Res Commun; 1994 Sep; 203(3):1423-31. PubMed ID: 7945290
[TBL] [Abstract][Full Text] [Related]
14. Regulation of expression and activity of four PKC isozymes in confluent and mechanically stimulated UMR-108 osteoblastic cells.
Geng WD; Boskovic G; Fultz ME; Li C; Niles RM; Ohno S; Wright GL
J Cell Physiol; 2001 Nov; 189(2):216-28. PubMed ID: 11598907
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of the 41- and 43-kDa mitogen-activated protein (MAP) kinases in the progression of prostate cancer to an androgen-independent state.
Oka H; Chatani Y; Kohno M; Kawakita M; Ogawa O
Int J Urol; 2005 Oct; 12(10):899-905. PubMed ID: 16323984
[TBL] [Abstract][Full Text] [Related]
16. Expression of protein kinase C genes in normal (+/+) and W mutant alleles (Wsh/Wsh, W/Wv) mice testes.
Kim HM; Jin E; Park ST; Kim JJ; Yoon HS; Oh YK; Oh KS; Chung YT
Immunopharmacol Immunotoxicol; 2000 Feb; 22(1):91-102. PubMed ID: 10737259
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells.
Perletti GP; Folini M; Lin HC; Mischak H; Piccinini F; Tashjian AH
Oncogene; 1996 Feb; 12(4):847-54. PubMed ID: 8632907
[TBL] [Abstract][Full Text] [Related]
18. Oncodevelopmental enzymes of the Dunning rat prostatic adenocarcinoma.
Hall M; Silverman L; Wenger AS; Mickey DD
Cancer Res; 1985 Sep; 45(9):4053-9. PubMed ID: 2992772
[TBL] [Abstract][Full Text] [Related]
19. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C
Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526
[TBL] [Abstract][Full Text] [Related]
20. Characterization of patterns of expression of protein kinase C-alpha, -delta, -eta, -gamma and -zeta and their correlations to p53, galectin-3, the retinoic acid receptor-beta and the macrophage migration inhibitory factor (MIF) in human cholesteatomas.
Ghanooni R; Decaestecker C; Simon P; Gabius HJ; Hassid S; Choufani G
Hear Res; 2006 Apr; 214(1-2):7-16. PubMed ID: 16513304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
